11 Interstitial Lung Disease Clinical Trials in Seattle, WA (2026)

Q: How do I join a clinical trial in Seattle?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you.

Recruiting Interstitial Lung Disease Studies in Seattle

NCT06722378Recruiting

A Trial to Improve Family Clinical Note Access and Outcomes for Hospitalized Children

This study will test if giving parents access to their child's medical notes on a bedside tablet: * helps them get more involved in their care * helps identify safety concerns Parents of hospitalize...

Seattle, WA630 participantsUniversity of Wisconsin, Madison

View Study Details

NCT06855329Recruiting

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

This is a prospective, observational cohort study. Participants with non-idiopatic pulmonary fibrosis, interstitial lung disease (ILD) will be followed for 24 months to systematically collect clinical...

Seattle, WA500 participantsUniversity of Massachusetts, Worcester

View Study Details

NCT06586723Recruiting

Impact Trial of Helping Educational Leaders Mobilize Evidence

Social, emotional, and behavioral (SEB) problems occur frequently among elementary school students, dramatically impede student outcomes, and have been exacerbated by the COVID-19 pandemic. Evidence b...

Seattle, WA400 participantsUniversity of Washington

View Study Details

NCT06859996Recruiting

CORE (Cognitive Optimization Through Rehabilitation and Education) Study

Mild traumatic brain injury (mTBI) affects millions of individuals worldwide every year. It has long been thought that the vast majority of individuals who sustain a mTBI experience natural recovery w...

Seattle, WA354 participantsUniversity of Washington

View Study Details

NCT07009288Recruiting

A Study of Time-Restricted Eating in Childhood Cancer Survivors

This study will look at whether motivational sessions (including regular calls with a trained health coach) in combination with time-restricted eating (TRE) is an effective way to achieve weight loss ...

Seattle, WA300 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05989568Recruiting

BASIS-T Efficacy Trial

For the approximately one in five children with social, emotional, and behavioral (SEB) challenges, accessible evidence-based prevention practices (EBPPs) are critical. In the United States, schools a...

Seattle, WA276 participantsUniversity of Washington

View Study Details

NCT06817122Recruiting

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

The goal of this research is to educate people about different technologies to support care at home when someone is experiencing memory difficulties. "Let's Talk Tech" is a new tool to educate people ...

Seattle, WA240 participantsUniversity of Washington

View Study Details

NCT06601933Recruiting

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Effective, clinically meaningful treatments are lacking for patients with mild cognitive impairment (MCI), which is associated with increased risk of transition to dementia. Cognitive training represe...

Seattle, WA240 participantsColumbia University

View Study Details

NCT06232304Recruiting

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSL...

Seattle, WA175 participantsMichigan State University

View Study Details

NCT06552013Recruiting

Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention

The goal of this randomized control trial is to learn if box fans and filters can reduce asthma symptoms and improve indoor air quality in children ages 6 - 17 years old with asthma living in the Duwa...

Seattle, WA80 participantsUniversity of Washington

View Study Details

NCT06609928Recruiting

FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

This phase I trial tests the safety, side effects, and best dose of FH-FOLR1 chimeric antigen receptor (CAR) T cells in treating pediatric patients with FOLR1+ acute myeloid leukemia (AML) that has co...

Seattle, WA12 participantsFred Hutchinson Cancer Center

View Study Details

About Interstitial Lung Disease Clinical Trials in Seattle

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 11 interstitial lung disease clinical trials recruiting participants in Seattle, WA. These studies are seeking a combined 3,207 participants. Research is being sponsored by University of Wisconsin, Madison, University of Massachusetts, Worcester, University of Washington and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Seattle — FAQ

Are there interstitial lung disease clinical trials in Seattle?

Yes, there are 11 interstitial lung disease clinical trials currently recruiting in Seattle, WA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Seattle?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.

Are clinical trials in Seattle free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 11 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 13, 2026 from ClinicalTrials.gov